The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Current use of PSMA–PET in prostate cancer management
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
ESUR prostate MR guidelines 2012
Barentsz, J. O., Richenberg, J., Clements, R., Choyke, P., Verma, S., Villeirs, G., Rouviere, O., Logager, V., & Fütterer, J. J. (2012) · European Radiology · doi:10.1007/s00330-011-2377-y · Cited by 2,438
(1997) · PubMed · Cited by 1,541
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.003 · Cited by 1,113
Eiber, M., Maurer, T., Souvatzoglou, M., Beer, A. J., Ruffani, A., Haller, B., Graner, F.-P., Kübler, H., Haberhorn, U., Eisenhut, M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154153 · Cited by 994
Self-citationAfshar-Oromieh, A., Avtzi, E., Giesel, F. L., Holland-Letz, T., Linhart, H. G., Eder, M., Eisenhut, M., Boxler, S., Hadaschik, B. A., Kratochwil, C., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2949-6 · Cited by 964
Hövels, A. M., Heesakkers, R. A. M., Adang, E. M., Jager, G. J., Strum, S., Hoogeveen, Y. L., Severens, J. L., & Barentsz, J. O. (2008) · Clinical Radiology · doi:10.1016/j.crad.2007.05.022 · Cited by 954
Afshar-Oromieh, A., Zechmann, C. M., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Holland-Letz, T., Hadaschik, B. A., Giesel, F. L., Debus, J., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2525-5 · Cited by 921
Afshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Hadaschik, B. A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2298-2 · Cited by 915
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
Ghosh, A., & Heston, W. D. W. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10661 · Cited by 878
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Eder, M., Schäfer, M., Bauder-Wüst, U., Hull, W.-E., Wängler, C., Mier, W., Haberkorn, U., & Eisenhut, M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200279b · Cited by 843
Chang, S. S., Reuter, V. E., Heston, W. D. W., Bander, N. H., Grauer, L. S., & Gaudin, P. B. (1999) · PubMed · Cited by 825
Maurer, T., Gschwend, J. E., Rauscher, I., Souvatzoglou, M., Haller, B., Weirich, G., Wester, H.-J., Heck, M., Kübler, H., Beer, A. J., et al. (2016) · Journal of Urology · doi:10.1016/j.juro.2015.12.025 · Cited by 779
Self-citationBostwick, D. G., Pacelli, A., Blute, M., Roche, P., & Murphy, G. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11<2256::aid-cncr22>3.0.co;2-s · Cited by 698
Benešová, M., Schäfer, M., Bauder-Wüst, U., Afshar-Oromieh, A., Kratochwil, C., Mier, W., Haberkorn, U., Kopka, K., & Eder, M. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.147413 · Cited by 612
Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
Eiber, M., Weirich, G., Holzapfel, K., Souvatzoglou, M., Haller, B., Rauscher, I., Beer, A. J., Wester, H.-J., Gschwend, J., Schwaiger, M., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.12.053 · Cited by 568
Self-citationWeineisen, M., Schottelius, M., Simecek, J., Baum, R. P., Yildiz, A., Beykan, S., Kulkarni, H. R., Lassmann, M., Klette, I., Eiber, M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.158550 · Cited by 532
Self-citationFütterer, J. J., Heijmink, S. W. T. P. J., Scheenen, T. W. J., Veltman, J., Huisman, H. J., Vos, P., de Kaa, C. A. H., Witjes, J. A., Krabbe, P. F. M., Heerschap, A., et al. (2006) · Radiology · doi:10.1148/radiol.2412051866 · Cited by 518
Pathological and molecular aspects of prostate cancer
DeMarzo, A. M., Nelson, W. G., Isaacs, W. B., & Epstein, J. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12779-1 · Cited by 472
Prostate-specific membrane antigen is produced in tumor-associated neovasculature.
Chang, S. S., O’Keefe, D. S., Bacich, D. J., Reuter, V. E., Heston, W. D. W., & Gaudin, P. B. (1999) · PubMed · Cited by 471
Valerio, M., Donaldson, I., Emberton, M., Ehdaie, B., Hadaschik, B. A., Marks, L. S., Mozer, P., Rastinehad, A. R., & Ahmed, H. U. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.026 · Cited by 458
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., & Bander, N. H. (1998) · PubMed · Cited by 458
Szabo, Z., Mena, E., Rowe, S. P., Plyku, D., Nidal, R., Eisenberger, M. A., Antonarakis, E. S., Fan, H., Dannals, R. F., Chen, Y., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0850-8 · Cited by 443
Afshar-Oromieh, A., Hetzheim, H., Kratochwil, C., Benesova, M., Eder, M., Neels, O. C., Eisenhut, M., Kübler, W., Holland-Letz, T., Giesel, F. L., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161299 · Cited by 427
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Holland, J. P., Divilov, V., Bander, N. H., Smith-Jones, P. M., Larson, S. M., & Lewis, J. S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.076174 · Cited by 418
Chen, Y., Pullambhatla, M., Foss, C. A., Byun, Y., Nimmagadda, S., Senthamizhchelvan, S., Sgouros, G., Mease, R. C., & Pomper, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1357 · Cited by 388
Mannweiler, S., Amersdorfer, P., Trajanoski, S., Terrett, J. A., King, D., & Mehes, G. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-008-9104-2 · Cited by 384
Trover, J. K., Beckett, M. L., & Wright, G. L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620511 · Cited by 373
Carter, R. E., Feldman, A. R., & Coyle, J. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.749 · Cited by 372
Krause, B. J., Souvatzoglou, M., Tuncel, M., Herrmann, K., Buck, A. K., Praus, C., Schuster, T., Geinitz, H., Treiber, U., & Schwaiger, M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0581-4 · Cited by 367
Self-citationDietlein, M., Kobe, C., Kuhnert, G., Stockter, S., Fischer, T., Schomäcker, K., Schmidt, M., Dietlein, F., Zlatopolskiy, B. D., Krapf, P., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0866-0 · Cited by 355
Umbehr, M. H., Müntener, M., Hany, T., Sulser, T., & Bachmann, L. M. (2013) · European Urology · doi:10.1016/j.eururo.2013.04.019 · Cited by 354
Afshar-Oromieh, A., Haberkorn, U., Eder, M., Eisenhut, M., & Zechmann, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2069-0 · Cited by 325
Delker, A., Fendler, W. P., Kratochwil, C., Brunegraf, A., Gosewisch, A., Gildehaus, F. J., Tritschler, S., Stief, C. G., Kopka, K., Haberkorn, U., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3174-7 · Cited by 322
Evans, M. J., Smith-Jones, P. M., Wongvipat, J., Navarro, V., Kim, S., Bander, N. H., Larson, S. M., & Sawyers, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106383108 · Cited by 316
Hillier, S. M., Maresca, K. P., Femia, F. J., Marquis, J. C., Foss, C. A., Nguyen, N., Zimmerman, C. N., Barrett, J. A., Eckelman, W. C., Pomper, M. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1682 · Cited by 316
Heesakkers, R. A., Hövels, A. M., Jager, G. J., van den Bosch, H. C., Witjes, J. A., Raat, H. P., Severens, J. L., Adang, E. M., van der Kaa, C. H., Fütterer, J. J., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70203-1 · Cited by 307
Robinson, M. B., Blakely, R. D., Couto, R., & Coyle, J. T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47823-4 · Cited by 306
THE RELATIVE IMPACT AND FUTURE BURDEN OF PROSTATE CANCER IN THE UNITED STATES
CHAN, J. M., JOU, R. M., & CARROLL, P. R. (2004) · Journal of Urology · doi:10.1097/01.ju.0000142068.66876.53 · Cited by 303
Lecouvet, F. E., El Mouedden, J., Collette, L., Coche, E., Danse, E., Jamar, F., Machiels, J.-P., Vande Berg, B., Omoumi, P., & Tombal, B. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.020 · Cited by 303
Maresca, K. P., Hillier, S. M., Femia, F. J., Keith, D., Barone, C., Joyal, J. L., Zimmerman, C. N., Kozikowski, A. P., Barrett, J. A., Eckelman, W. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800994j · Cited by 295
Ahmadzadehfar, H., Rahbar, K., Kürpig, S., Bögemann, M., Claesener, M., Eppard, E., Gärtner, F., Rogenhofer, S., Schäfers, M., & Essler, M. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0114-2 · Cited by 293
Cho, S. Y., Gage, K. L., Mease, R. C., Senthamizhchelvan, S., Holt, D. P., Jeffrey-Kwanisai, A., Endres, C. J., Dannals, R. F., Sgouros, G., Lodge, M., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.104661 · Cited by 279
Evangelista, L., Guttilla, A., Zattoni, F., Muzzio, P. C., & Zattoni, F. (2013) · European Urology · doi:10.1016/j.eururo.2012.09.039 · Cited by 278
Beheshti, M., Imamovic, L., Broinger, G., Vali, R., Waldenberger, P., Stoiber, F., Nader, M., Gruy, B., Janetschek, G., & Langsteger, W. (2010) · Radiology · doi:10.1148/radiol.09090413 · Cited by 270
Issa, B. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10139 · Cited by 243
Oto, A., Yang, C., Kayhan, A., Tretiakova, M., Antic, T., Schmid-Tannwald, C., Eggener, S., Karczmar, G. S., & Stadler, W. M. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.11.6861 · Cited by 242
Haffner, M. C., Kronberger, I. E., Ross, J. S., Sheehan, C. E., Zitt, M., Mühlmann, G., Öfner, D., Zelger, B., Ensinger, C., Yang, X. J., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.003 · Cited by 236
Transition Zone Prostate Cancer: Detection and Localization with 3-T Multiparametric MR Imaging
Hoeks, C. M. A., Hambrock, T., Yakar, D., Hulsbergen–van de Kaa, C. A., Feuth, T., Witjes, J. A., Fütterer, J. J., & Barentsz, J. O. (2013) · Radiology · doi:10.1148/radiol.12120281 · Cited by 235
Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
Maurer, T., Weirich, G., Schottelius, M., Weineisen, M., Frisch, B., Okur, A., Kübler, H., Thalgott, M., Navab, N., Schwaiger, M., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.04.034 · Cited by 233
Self-citationThe homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
Schülke, N., Varlamova, O. A., Donovan, G. P., Ma, D., Gardner, J. P., Morrissey, D. M., Arrigale, R. R., Zhan, C., Chodera, A. J., Surowitz, K. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735443100 · Cited by 232
Rajasekaran, S. A., Anilkumar, G., Oshima, E., Bowie, J. U., Liu, H., Heston, W., Bander, N. H., & Rajasekaran, A. K. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-11-0731 · Cited by 226
Mease, R. C., Dusich, C. L., Foss, C. A., Ravert, H. T., Dannals, R. F., Seidel, J., Prideaux, A., Fox, J. J., Sgouros, G., Kozikowski, A. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1517 · Cited by 223
The Timing of Salvage Radiotherapy After Radical Prostatectomy: A Systematic Review
King, C. R. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.069 · Cited by 217
O’Keefe, D. S., Su, S. L., Bacich, D. J., Horiguchi, Y., Luo, Y., Powell, C. T., Zandvliet, D., Russell, P. J., Molloy, P. L., Nowak, N. J., et al. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00200-0 · Cited by 202
Schöder, H., Herrmann, K., Gönen, M., Hricak, H., Eberhard, S., Scardino, P., Scher, H. I., & Larson, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0249 · Cited by 202
Early Salvage Radiotherapy Following Radical Prostatectomy
Pfister, D., Bolla, M., Briganti, A., Carroll, P., Cozzarini, C., Joniau, S., van Poppel, H., Roach, M., Stephenson, A., Wiegel, T., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.013 · Cited by 200
18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
Rowe, S. P., Gage, K. L., Faraj, S. F., Macura, K. J., Cornish, T. C., Gonzalez-Roibon, N., Guner, G., Munari, E., Partin, A. W., Pavlovich, C. P., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154336 · Cited by 196
Roesch, F., & J. Riss, P. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610793176738 · Cited by 187
PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
Mease, R. C., Foss, C. A., & Pomper, M. G. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313080008 · Cited by 185
Krohn, T., Verburg, F. A., Pufe, T., Neuhuber, W., Vogg, A., Heinzel, A., Mottaghy, F. M., & Behrendt, F. F. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2915-3 · Cited by 180
Weineisen, M., Simecek, J., Schottelius, M., Schwaiger, M., & Wester, H.-J. (2014) · EJNMMI Research · doi:10.1186/s13550-014-0063-1 · Cited by 179
Self-citationImaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Rowe, S. P., Gorin, M. A., Hammers, H. J., Som Javadi, M., Hawasli, H., Szabo, Z., Cho, S. Y., Pomper, M. G., & Allaf, M. E. (2015) · Annals of Nuclear Medicine · doi:10.1007/s12149-015-1017-z · Cited by 172
Kularatne, S. A., Zhou, Z., Yang, J., Post, C. B., & Low, P. S. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000712 · Cited by 171
Beresford, M. J., Gillatt, D., Benson, R. J., & Ajithkumar, T. (2010) · Clinical Oncology · doi:10.1016/j.clon.2009.10.015 · Cited by 170
Kim, J. K., Kim, K. A., Park, B., Kim, N., & Cho, K. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21480 · Cited by 167
Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations
Jadvar, H. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2361-7 · Cited by 158
Wu, L., Xu, J.-R., Ye, Y., Lü, Q., & Hu, J. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7634 · Cited by 154
Eiber, M., Beer, A. J., Holzapfel, K., Tauber, R., Ganter, C., Weirich, G., Krause, B. J., Rummeny, E. J., & Gaa, J. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e3181bbdc2f · Cited by 153
Self-citationAnti–prostate‐Specific membrane antigen‐based radioimmunotherapy for prostate cancer
Tagawa, S. T., Beltran, H., Vallabhajosula, S., Goldsmith, S. J., Osborne, J. R., Matulich, D., Petrillo, K., Parmar, S., Nanus, D. M., & Bander, N. H. (2010) · Cancer · doi:10.1002/cncr.24795 · Cited by 144
Kabasakal, L., Demirci, E., Ocak, M., Akyel, R., Nematyazar, J., Aygün, A., Halaç, M., Talat, Z., & Araman, A. O. (2015) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000290 · Cited by 138
Brogsitter, C., Zöphel, K., & Kotzerke, J. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2358-2 · Cited by 134
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen
Chang, S. S., Reuter, V. E., Heston, W. D. W., & Gaudin, P. B. (2001) · Urology · doi:10.1016/s0090-4295(00)01094-3 · Cited by 133
First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT
Verburg, F. A., Krohn, T., Heinzel, A., Mottaghy, F. M., & Behrendt, F. F. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3065-y · Cited by 132
Heston, W. (1997) · Urology · doi:10.1016/s0090-4295(97)00177-5 · Cited by 130
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer
Souvatzoglou, M., Eiber, M. J., Takei, T., Fürst, S., Maurer, T., Gaertner, F. C., Geinitz, H., Drzezga, A. E., Ziegler, S. I., Nekolla, S. G., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2467-y · Cited by 111
Self-citationSchottelius, M., Wirtz, M., Eiber, M. J., et al. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0147-6 · Cited by 101
Self-citationGrauer, L. S., Lawler, K. D., Marignac, J. L., Kumar, A., Goel, A. S., & Wolfert, R. L. (1998) · PubMed · Cited by 98
Prostate-specific membrane antigen: evidence for the existence of a second related human gene
Leek, J. P., Lench, N., Maraj, B. H., Bailey, A., Carr, I., Andersen, S., Cross, J., Whelan, P. S., MacLennan, K., Meredith, D. M., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.377 · Cited by 90
Lu, G., Maresca, K. P., Hillier, S., Zimmerman, C. N., Eckelman, W. C., Joyal, J. L., & Babich, J. W. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.014 · Cited by 89
Elsässer‐Beile, U., Reischl, G., Wiehr, S., Bühler, P., Wolf, P., Alt, K., Shively, J. E., Judenhofer, M. S., Machulla, H. ‐., & Pichler, B. J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058487 · Cited by 89
Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).
Luthi‐Carter, R., Barczak, A. K., Speno, H. S., & Coyle, J. T. (1998) · PubMed · Cited by 88
68Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer
Eiber, M. J., Nekolla, S. G., Maurer, T., Weirich, G., Wester, H., & Schwaiger, M. (2014) · Abdominal Imaging · doi:10.1007/s00261-014-0301-z · Cited by 81
Self-citationMultimodal image-guided prostate fusion biopsy based on automatic deformable registration
Zettinig, O., Shah, A. M., Hennersperger, C., Eiber, M. J., Kroll, C., Kübler, H. R., Maurer, T., Milletarì, F., Rackerseder, J., zu Berge, C. S., et al. (2015) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-015-1233-y · Cited by 79
Self-citationBioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies
Wang, H., Byun, Y., Bařinka, C., Pullambhatla, M., Bhang, H. C., Fox, J. J., Lubkowski, J. T., Mease, R. C., & Pomper, M. G. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.061 · Cited by 79
Jacobs, M. A., Ouwerkerk, R., Petrowski, K., & Macura, K. J. (2008) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e3181aa6b50 · Cited by 70
Rischpler, C., Maurer, T., Schwaiger, M., & Eiber, M. J. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3235-y · Cited by 69
Self-citationSamplaski, M. K., Heston, W. D. W., Elson, P. J., Magi‐Galluzzi, C., & Hansel, D. E. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.112 · Cited by 64
A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA)
Banerjee, S. R., Pullambhatla, M., Shallal, H. M., Lisok, A., Mease, R. C., & Pomper, M. G. (2011) · Oncotarget · doi:10.18632/oncotarget.415 · Cited by 60
PET/MR in prostate cancer: technical aspects and potential diagnostic value
Souvatzoglou, M., Eiber, M. J., Martínez-Möller, A., Fürst, S., Holzapfel, K., Maurer, T., Ziegler, S. I., Nekolla, S. G., Schwaiger, M., & Beer, A. J. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2445-4 · Cited by 58
Self-citationRowe, S. P., Gorin, M. A., Hammers, H. J., Pomper, M. G., Allaf, M. E., & Javadi, M. S. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000995 · Cited by 57
Manenti, G., Squillaci, E., Roma, M. D., Carlani, M., Mancino, S., & Simonetti, G. (2006) · La radiologia medica · doi:10.1007/s11547-006-0110-8 · Cited by 42
Birtle, A. J., Freeman, A., Masters, J. R., Payne, H. A., Harland, S. J., & contributors to the BAUS Section of Oncology Cancer Registry (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05619.x · Cited by 33
Kjölhede, H., Ahlgren, G., Almquist, H., Liedberg, F., Lyttkens, K., Ohlsson, T., & Ola Bratt, A. (2013) · World Journal of Urology · doi:10.1007/s00345-013-1189-x · Cited by 25
Wiehr, S., Bühler, P., Gierschner, D., Wolf, P., Rolle, A.-M., Kesenheimer, C., Pichler, B. J., & Elsässer‐Beile, U. (2014) · The Prostate · doi:10.1002/pros.22794 · Cited by 17
Cited by
Radiopharmaceutical therapy in cancer: clinical advances and challenges
Sgouros, G., Bodei, L., McDevitt, M. R., & Nedrow, J. R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0073-9 · Cited by 963
Perera, M., Papa, N., Roberts, M., Williams, M., Udovicich, C., Vela, I., Christidis, D., Bolton, D., Hofman, M. S., Lawrentschuk, N., et al. (2020) · European Urology · doi:10.1016/j.eururo.2019.01.049 · Cited by 958
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 425
Metadata
- Authors
- Maurer, T., Eiber, M., Schwaiger, M., & Gschwend, J. E.
- Venue
- Nature Reviews Urology
- Published
- 2016-02-23
- Volume
- 13
- Issue
- 4
- Pages
- 226-235
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W2287868019
- Cited by
- 611
- References
- 97
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.